Hypertrophic obstructive cardiomyopathy: the mitral valve could be the key

Area of Science:

• Cardiovascular Surgery
• Cardiology
• Cardiac Surgery

Background:

• Hypertrophic obstructive cardiomyopathy (HOCM) is often associated with mitral valve abnormalities.
• Mitral valve pathology, including leaflet size and geometry, plays a crucial role in HOCM.
• Surgical correction of obstruction in HOCM typically involves septal resection.

Purpose of the Study:

• To evaluate the mid-term outcomes of systematically correcting mitral valve abnormalities in patients with HOCM.
• To assess the efficacy of a two-stage surgical procedure addressing both septal obstruction and mitral valve pathology.
• To determine if mitral valve intervention is a key component in HOCM treatment.

Main Methods:

• 16 symptomatic HOCM patients (NYHA class 3-4) underwent a two-stage surgical procedure.
• Stage 1: Septal resection via aortic valve and detached anterior mitral leaflet.
• Stage 2: Mitral valve repair (leaflet resection/neochordae, pericardial patch augmentation).

Main Results:

• No in-hospital or late mortality observed.
• All patients improved to NYHA Class 1 at follow-up.
• Significant reduction in mitral regurgitation (MR) and intraventricular gradient (mean 15 mmHg).

Conclusions:

• Mitral valve pathology is a critical component of HOCM that requires surgical attention.
• A two-stage procedure addressing both septal and mitral valve issues yields good mid-term results.
• Further investigation into isolated mitral valve treatment for HOCM may be warranted.